The fate of mitral homograft valve prosthesis implanted in tricuspid position
Tricuspid valve surgery is performed less frequently than other heart valve surgeries, and displacement constitutes a very limited portion of these surgeries. Valve selection during the replacement remains controversial. Although bioprosthetic valves are currently the most preferred prostheses, mitral homografts, which are biological materials with proven long-term durability, have also been used for this surgery. Herein, a 35-year-old male patient who underwent tricuspid valve replacement using a mitral homograft with a durability of 18 years was presented. This case highlights the first mitral homograft produced using the country's own resources and implanted in the tricuspid position.
Authors
- Mahsati Akhundova (ORCID: https://orcid.org/0000-0002-1679-8016)
Publication Details
- Journal
- Cardiovascular Surgery and Interventions
- Published
- 2024-10-21
- DOI
- https://doi.org/10.5606/e-cvsi.2024.1738
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00